QualityStocks Stock Newsletters Archives - Page 1707 of 1818

MondayJan 01, 2007 7:46 am

SmallCapVoice Client: Southridge Technology Group Inc. (SOUT)

RxElite Holdings, Inc., a wholly owned subsidiary of Southridge Technologies Group Inc., develops, manufactures, and markets generic prescription drug products in specialty generic markets. Key markets include anesthesia, sterile liquid dose drugs, and transdermal patch products. RxElite Holdings, Inc. recently closed a $19.6 Million Financing. Recent Drug Approval/ High Barriers With Limited Competition: Sevoflurane, the Company’s primary product was approved in May 2007. RxElite has the exclusive US rights to this product, a $400 M market with only two competitors. High barriers to additional competition include manufacturing process patents, limited manufacturing capacity, and unique chemistry expertise requirements. Distribution Strength and…

MondayJan 01, 2007 7:41 am

SmallCapVoice Client: Benda Pharmaceutical Inc. (BPMA)

Benda Pharmaceutical, Inc. (www.bendapharma.com), a China-based pharmaceutical company, is a pure play on explosive Chinese pharmaceutical spending and the global search for a cancer cure. Benda produces traditional Chinese and conventional medicines, as well as Gendicine®, the world's first commercialized gene therapy medicine for the treatment of cancer. For more information, please visit: http://www.qualitystocks.net/partners.php?partnerid=scvoice

MondayJan 01, 2007 7:29 am

SmallCapVoice Client: Technest Holdings Inc. (TCNH)

Technest Holdings, Inc. is a provider of: advanced remote sensor systems, chemical detectors, intelligent surveillance and advanced 3D imaging technology solutions to the defense and homeland security marketplaces. Technest is committed to setting next-generation standards in defense and security through the provision of innovative emerging technologies and expert services. Technest's solutions support military, law enforcement and homeland security personnel. Through strategic development, Technest focuses on the creation of dual-use technology and products with applications in both the defense market and civilian homeland security and law enforcement fields. For more information, please visit the company's website at http://www.technestholdings.com. For more information,…

MondayJan 01, 2007 7:15 am

SmallCapVoice Client: eTELCHARGE.com Inc. (ETLC)

ETELCHARGE provides secure payment options for online purchases. ETELCHARGE's secure online payment system gives online members the ability to charge goods and services purchased over the Internet directly to their phone bill. ETELCHARGE provides online merchants with a way to accept purchases from customers who do not have credit cards or banking relationships. For more information, please visit: http://www.qualitystocks.net/partners.php?partnerid=scvoice

MondayJan 01, 2007 7:03 am

SmallCapVoice Client: Material Technologies Inc. (MTTG)

Material Technologies Inc., also known as MATECH, was founded in 1983 and is based in Los Angeles. It is an engineering, research and development company that specializes in technologies to measure microscopic fractures in metal structures and to monitor metal fatigue. The Company has already completed significant work for the federal government -- generating $8.3 million to develop technology to detect metal fatigue in aircraft. It has also received $5 million in private investments. Building on that base of experience and capital, it is now beginning to market its technologies to companies and government agencies involved in the inspection…

MondayJan 01, 2007 6:47 am

SmallCapVoice Client:Sweet Success Enterprises Inc (SWTS)

San Antonio-based Sweet Success Enterprises Inc. acquired Nestlé’s original Sweet Success™ brand and has re-launched as Fuel for Health™; an all natural product line to tap into the rapidly growing demand for all natural and self stable health and wellness beverages. Sweet Success is now available in a growing number of stores and includes select ingredients to satiate, boost energy and immunity and enhance a healthy lifestyle. Sweet Success® contracts for the production, marketing and distribution of all-natural beverages under the brand names Sweet Success® Fuel For Health™. The Sweet Success product line includes: GlucaSafe, a functional health beverage with…

MondayJan 01, 2007 6:46 am

SmallCapVoice Client: Neostem Inc. (NBS)

NeoStem is a biotechnology services company enhancing the delivery of adult stem cell therapeutics to health-conscious consumers. The Company is developing a nationwide network of adult stem cell collection centers, enabling people to donate and store their own stem cells with NeoStem for personal use years or decades later in times of critical medical need. Although adult stem cell therapies are generally not standard of care, the Company believes medicine is on the threshold of a plethora of such new therapies. The proprietary NeoStem technologies empower health-conscious consumers to help protect their future health by undergoing treatment with their…

MondayJan 01, 2007 6:13 am

Immune Response (OTCBB: IMNR) Secures Partners for MS Clinical Trials

Immune Response Corporation recently announced on that it has entered into an agreement with Accelsiors CRO & Consultancy Services, a clinical research organization with extensive experience in conducting multiple sclerosis (MS) trials, to oversee the 200-patient Phase II trial of NeuroVax, an investigational T-cell receptor peptide vaccine for the treatment of MS. Immune went on further to announce that in November they will hold a clinical trial meeting in Budapest, Hungary to discuss plans for a multi-center trial. This trial will also be a double-blind placebo control test to further investigate the viability of NeuroVax as a treatment for MS.…

MondayJan 01, 2007 6:13 am

Axial Vector Engine (OTCBB: AXVC) Receives New Financing

Axial Vector Engine Corp recently announced that it was closing its private placement after receiving $2.7M from its investors at $2.00 per share. Dr. Raymond Brouzes, President and CEO of Axial Vector stated, "We are extremely pleased by the support of our shareholders who provided this very favorable financing to the company. Our development and patenting program continues full speed ahead. We will be premiering our new low cost Power Generating Technologies at the 'World Power Generation Show ' November 28 -30 in Orlando Florida." This announcement followed on the heels of their recent patent filing for their broad intellectual…

MondayJan 01, 2007 6:13 am

Xechem’s (OTCBB: XKEM) Orphan Drug Status Approved for New Sickle Cell Drug

Recently, the EU approved "Orphan Drug Status" for Xechem International's sickle cell drug dubbed Niprisan, a phytopharmaceutical product that has shown efficacy in the treatment of Sickle Cell Disease. The designation covers all 25 member countries that comprise the European Union. A similar Orphan Drug Status was granted to Xechem by the U.S. Food and Drug Administration. Dr. Ramesh Pandey, Xechem's Chairman & CEO said, "Obtaining Orphan Drug status for our Sickle Cell Disease product in both the European Union and the United States brings to Xechem substantial advantages and incentives which will help facilitate approval of the drug and…

Site Search

Company Search

Category: QualityStocks Stock Newsletters

SmallCapVoice Client: Southridge Technology Group Inc. (SOUT)

SmallCapVoice Client: Benda Pharmaceutical Inc. (BPMA)

SmallCapVoice Client: Technest Holdings Inc. (TCNH)

SmallCapVoice Client: eTELCHARGE.com Inc. (ETLC)

SmallCapVoice Client: Material Technologies Inc. (MTTG)

SmallCapVoice Client:Sweet Success Enterprises Inc (SWTS)

SmallCapVoice Client: Neostem Inc. (NBS)

Immune Response (OTCBB: IMNR) Secures Partners for MS Clinical Trials

Axial Vector Engine (OTCBB: AXVC) Receives New Financing

Xechem’s (OTCBB: XKEM) Orphan Drug Status Approved for New Sickle Cell Drug

Market Basics

Newsletter Publishers

Public Companies